Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment (POPular Genetics)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01761786 |
Recruitment Status :
Completed
First Posted : January 7, 2013
Last Update Posted : May 10, 2019
|
Sponsor:
Vera HM Deneer
Collaborators:
Isala
Meander Medical Center
UMC Utrecht
University Medical Center Groningen
OLVG
Onze Lieve Vrouw Hospital
Amphia Hospital
ZonMw: The Netherlands Organisation for Health Research and Development
Federico II University
Rijnstate Hospital
Information provided by (Responsible Party):
Vera HM Deneer, St. Antonius Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 4, 2019 |
Actual Study Completion Date : | April 4, 2019 |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):